-
The authors concluded that systematically obtaining family history identifies more subjects with high CV risk who may benefit from more aggressive preventive interventions.
-
Vitamin D deficiency is associated with a significant risk of cardiovascular disease and reduced survival. Vitamin D supplementation improved survival, especially in patients with documented deficiency.
-
A new selective phosphodiesterase type 5 (PDE5) inhibitor has been approved for treating erectile dysfunction (ED). Avanafil was developed by Mitsubishi Tanabe Pharma Corporation in Japan and is manufactured in Japan and marketed by Vivus, Inc., as Stendra.
-
The authors conclude that in patients hospitalized with myocardial infarction, women were more likely than men to present without chest pain and had higher mortality than men within the same age group.
-
-
Knowledge of pediatric-specific antimicrobial susceptibility data improves prescribing selections of empiric antibiotic treatment. Providers should advocate for availability of pediatric-specific antimicrobial susceptibility data wherever practical.
-
-
-
Current guidelines recommend cardiac rehabilitation using moderate exercise programs for most ischemic heart disease (IHD) patients. Also, studies have shown that the intensity of exercise is directly related to the cardioprotective effects. However, there is concern that high-intensity exercise may be dangerous in IHD patients.
-
This systematic review and meta-analysis finds that the implementation of multidisciplinary tracheostomy teams leads to significant improvements in time to decannulation and in speaking valve use but not in ICU or hospital length of stay. The quality of the evidence was low.
